Sign In
Buy DVAX
$15.50
+0 (+0%)
At Close: May 08, 2026
Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix
09:02am, Friday, 19'th Jun 2020
A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters f
Sixth trial of potential Chinese Covid-19 shot begins with GSK, Dynavax mix
09:02am, Friday, 19'th Jun 2020
The trial, which is enrolling about 150 adult and elderly patients, will evaluate the two different boosters, or adjuvants, in combination with Clover’s candidate shot, SCB-2019, the Chinese company
Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix
08:54am, Friday, 19'th Jun 2020
A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters f
Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix
08:54am, Friday, 19'th Jun 2020
A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters f
Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix
08:52am, Friday, 19'th Jun 2020
A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters f
Dynavax Technologies : China's Clover begins human trials of COVID-19 shot with GSK, Dynavax boosters | MarketScreener
07:41am, Friday, 19'th Jun 2020China's Clover begins human trials of COVID-19 shot with GSK, Dynavax boosters
07:38am, Friday, 19'th Jun 2020Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
12:00am, Friday, 19'th Jun 2020
Clover Biopharmaceuticals today announced that the first participants have been dosed in the Phase 1 first-in-human study evaluating the company’s COV
3 Top Stocks Under $10 | The Motley Fool
02:15pm, Thursday, 18'th Jun 2020
One is developing a COVID-19 vaccine; the other two are from rebounding industries.
Medtronic : Self-Expanding Venous Stent Demonstrates Favorable Outcomes in Patients with Venous Outflow Obstruction | MarketScreener
11:42am, Wednesday, 17'th Jun 2020Medtronic : ABRE Study Meets Primary Safety and Effectiveness Endpoints | MarketScreener
11:32am, Wednesday, 17'th Jun 2020ABRE Study Meets Primary Safety and Effectiveness Endpoints | MarketScreener
04:01pm, Tuesday, 16'th Jun 20206 Stocks That Could Jump Higher
12:00am, Tuesday, 16'th Jun 2020
Stocks Analysis by Harry Boxer covering: Celsion Corp, Celldex Therapeutics Inc, Digital Ally Inc, Dynavax Technologies Corporation. Read Harry Boxer's latest article on Investing.com
Dynavax Stock Rises After Lofty Bull Note - Schaeffer's Investment Research
03:45pm, Monday, 15'th Jun 2020
Dynavax Technologies (DVAX) is up after Evercore ISI initiated coverage with an "outperform" rating and price target of $14
Karyopharm Brain Cancer Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:KPTI)
09:24am, Monday, 15'th Jun 2020
Karyopharm doses first patient in a phase 1/2 brain cancer trial. Dynavax completes enrolment for phase 1 clinical trial of Heplisav-B. BeyondSpring reports pos
